137 related articles for article (PubMed ID: 26819921)
21. Characterization of MDL 73005EF as a 5-HT1A selective ligand and its effects in animal models of anxiety: comparison with buspirone, 8-OH-DPAT and diazepam.
Moser PC; Tricklebank MD; Middlemiss DN; Mir AK; Hibert MF; Fozard JR
Br J Pharmacol; 1990 Feb; 99(2):343-9. PubMed ID: 1970269
[TBL] [Abstract][Full Text] [Related]
22. Acoustic startle, conditioned startle potentiation and the effects of 8-OH-DPAT and buspirone in rats selectively bred for differences in 8-OH-DPAT-induced hypothermia.
McQueen DA; Overstreet DH; Ardayfio PA; Commissaris RL
Behav Pharmacol; 2001 Nov; 12(6-7):509-16. PubMed ID: 11742145
[TBL] [Abstract][Full Text] [Related]
23. Drug-induced defaecation in rats: role of central 5-HT1A receptors.
Croci T; Landi M; Bianchetti A; Manara L
Br J Pharmacol; 1995 May; 115(1):203-9. PubMed ID: 7647978
[TBL] [Abstract][Full Text] [Related]
24. The firing activity of pyramidal neurons in medial prefrontal cortex and their response to 5-hydroxytryptamine-1A receptor stimulation in a rat model of Parkinson's disease.
Wang S; Zhang QJ; Liu J; Wu ZH; Ali U; Wang Y; Chen L; Gui ZH
Neuroscience; 2009 Sep; 162(4):1091-100. PubMed ID: 19410634
[TBL] [Abstract][Full Text] [Related]
25. The acute and chronic administration of (+/-)-8-hydroxy-2-(Di-n-propylamino)tetralin significantly alters the activity of spontaneously active midbrain dopamine neurons in rats: an in vivo electrophysiological study.
Nakamura K; Suzuki K; McCreary AC; Ashby CR
Synapse; 2006 May; 59(6):359-67. PubMed ID: 16463399
[TBL] [Abstract][Full Text] [Related]
26. Pre-treatment with silymarin reduces brain myeloperoxidase activity and inflammatory cytokines in 6-OHDA hemi-parkinsonian rats.
Haddadi R; Mohajjel Nayebi A; Brooshghalan SE
Neurosci Lett; 2013 Oct; 555():106-11. PubMed ID: 24045063
[TBL] [Abstract][Full Text] [Related]
27. Selective increase in carbohydrate intake by rats treated with 8-hydroxy-2-(di-n-propylamino)-tetraline or buspirone.
Luo SQ; Ransom T; Li ET
Life Sci; 1990; 46(23):1643-8. PubMed ID: 2141379
[TBL] [Abstract][Full Text] [Related]
28. Rotational behavior induced by 8-hydroxy-DPAT, a putative 5HT-1A agonist, in 6-hydroxydopamine-lesioned rats.
Gerber R; Altar CA; Liebman JM
Psychopharmacology (Berl); 1988; 94(2):178-82. PubMed ID: 2965396
[TBL] [Abstract][Full Text] [Related]
29. Reversal of fenfluramine and fluoxetine anorexia by 8-OH-DPAT is attenuated following raphe injection of 5,7-dihydroxytryptamine.
Currie PJ; Coscina DV; Fletcher PJ
Brain Res; 1998 Jul; 800(1):62-8. PubMed ID: 9685586
[TBL] [Abstract][Full Text] [Related]
30. 8-hydroxy-2-(di-n-propylamino)tetralin intervenes with neural cell apoptosis following diffuse axonal injury.
Mao Z; Song Z; Li G; Lv W; Zhao X; Li B; Feng X; Chen Y
Neural Regen Res; 2013 Jan; 8(2):133-42. PubMed ID: 25206483
[TBL] [Abstract][Full Text] [Related]
31. Serotonergic and dopaminergic mechanisms in graft-induced dyskinesia in a rat model of Parkinson's disease.
Shin E; Garcia J; Winkler C; Björklund A; Carta M
Neurobiol Dis; 2012 Sep; 47(3):393-406. PubMed ID: 22579773
[TBL] [Abstract][Full Text] [Related]
32. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
Tricklebank MD; Neill J; Kidd EJ; Fozard JR
Eur J Pharmacol; 1987 Jan; 133(1):47-56. PubMed ID: 2881789
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological suppression of the median raphe nucleus with serotonin1A agonists, 8-OH-DPAT and buspirone, produces hippocampal theta rhythm in the rat.
Vertes RP; Kinney GG; Kocsis B; Fortin WJ
Neuroscience; 1994 May; 60(2):441-51. PubMed ID: 8072690
[TBL] [Abstract][Full Text] [Related]
34. Alterations in the cellular distribution of bcl-2, bcl-x and bax in the adult rat substantia nigra following striatal 6-hydroxydopamine lesions.
Kramer BC; Mytilineou C
J Neurocytol; 2004 Mar; 33(2):213-23. PubMed ID: 15322379
[TBL] [Abstract][Full Text] [Related]
35. Inhibitory effect of buspirone and diazepam, but not of 8-OH-DPAT, on maternal behavior and aggression.
Ferreira A; Picazo O; Uriarte N; Pereira M; Fernández-Guasti A
Pharmacol Biochem Behav; 2000 Jun; 66(2):389-96. PubMed ID: 10880695
[TBL] [Abstract][Full Text] [Related]
36. [3H]8-OH-DPAT labels the 5-hydroxytryptamine uptake recognition site and the 5-HT1A binding site in the rat striatum.
Alexander BS; Wood MD
J Pharm Pharmacol; 1988 Dec; 40(12):888-91. PubMed ID: 2907586
[TBL] [Abstract][Full Text] [Related]
37. 6-Hydroxydopamine increases the level of TNFalpha and bax mRNA in the striatum and induces apoptosis of dopaminergic neurons in hemiparkinsonian rats.
Mladenović A; Perović M; Raicević N; Kanazir S; Rakić L; Ruzdijić S
Brain Res; 2004 Jan; 996(2):237-45. PubMed ID: 14697501
[TBL] [Abstract][Full Text] [Related]
38. Role of 5-Hydroxytryptamine 1A Receptors in 6-Hydroxydopmaine-induced Catalepsy-like Immobilization in Rats: a Therapeutic Approach for Treating Catalepsy of Parkinson's Disease.
Eyhani-Rad S; Mohajjel Nayebi A; Mahmoudi J; Samini M; Babapour V
Iran J Pharm Res; 2012; 11(4):1175-81. PubMed ID: 24250551
[TBL] [Abstract][Full Text] [Related]
39. Long-term fluoxetine, but not desipramine, inhibits the ACTH and oxytocin responses to the 5-HT1A agonist, 8-OH-DPAT, in male rats.
Li Q; Levy AD; Cabrera TM; Brownfield MS; Battaglia G; Van de Kar LD
Brain Res; 1993 Dec; 630(1-2):148-56. PubMed ID: 8118681
[TBL] [Abstract][Full Text] [Related]
40. Differential effects of 5-hydroxytryptamine1a selective drugs on the 5-HT behavioral syndrome.
Smith LM; Peroutka SJ
Pharmacol Biochem Behav; 1986 Jun; 24(6):1513-9. PubMed ID: 2942947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
